Detalles de la búsqueda
1.
Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland.
Future Oncol
; 20(8): 459-470, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37529943
2.
Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops.
Int J Technol Assess Health Care
; 36(2): 104-112, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32423520
3.
Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model.
Gynecol Oncol
; 153(1): 87-91, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30704745
4.
A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.
Value Health
; 20(4): 567-576, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407998
5.
Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis.
Dermatol Ther (Heidelb)
; 12(1): 185-194, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34877623
6.
Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
JAMA Netw Open
; 2(5): e194428, 2019 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31125106
Resultados
1 -
6
de 6
1
Próxima >
>>